Energetics of quadruplex-drug recognition in anticancer therapy

Area of Science:

• Oncology
• Biochemistry
• Drug Discovery

Background:

• Tumor cell immortality is maintained by telomerase, an enzyme overexpressed in ~85% of cancers.
• Telomerase activity prevents telomere shortening, unlike in normal somatic cells where it leads to apoptosis.
• Telomeric G-rich overhangs can form quadruplex structures that inhibit telomerase.

Purpose of the Study:

• To review the energetic aspects of drug-quadruplex interactions.
• To highlight the importance of understanding these interactions for drug design.
• To focus on physico-chemical methodologies for studying these complexes.

Main Methods:

• Review of existing literature on quadruplex-drug interactions.
• Discussion of energetic principles governing these interactions.
• Emphasis on physico-chemical techniques for analysis.

Main Results:

• Drug binding to quadruplex structures is a viable strategy for telomerase inhibition.
• Energetic characterization provides insights into drug recognition and binding affinity.
• Physico-chemical methods are crucial for detailed analysis of drug-quadruplex complexes.

Conclusions:

• Targeting telomerase through quadruplex-drug interactions offers a promising avenue for cancer treatment.
• Further research into the energetics and recognition mechanisms is essential for rational drug design.
• Physico-chemical methodologies are vital tools for advancing this field.